Altered drug translocation mediated by the MDR protein: direct, indirect, or both?
about
Expression of the AZR1 gene (ORF YGR224w), encoding a plasma membrane transporter of the major facilitator superfamily, is required for adaptation to acetic acid and resistance to azoles in Saccharomyces cerevisiae.The yeast ABC transporter Pdr18 (ORF YNR070w) controls plasma membrane sterol composition, playing a role in multidrug resistanceResistance and adaptation to quinidine in Saccharomyces cerevisiae: role of QDR1 (YIL120w), encoding a plasma membrane transporter of the major facilitator superfamily required for multidrug resistance.Saccharomyces cerevisiae multidrug resistance transporter Qdr2 is implicated in potassium uptake, providing a physiological advantage to quinidine-stressed cells.Merck Frosst Award Lecture 1998. Molecular dissection of the human multidrug resistance P-glycoprotein.Chloroquine resistance in the malarial parasite, Plasmodium falciparum.The dual role of candida glabrata drug:H+ antiporter CgAqr1 (ORF CAGL0J09944g) in antifungal drug and acetic acid resistance.Candida glabrata drug:H+ antiporter CgQdr2 confers imidazole drug resistance, being activated by transcription factor CgPdr1.Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?MFS transporters required for multidrug/multixenobiotic (MD/MX) resistance in the model yeast: understanding their physiological function through post-genomic approaches."Drug resistance associated membrane proteins".Designing multidrug-resistance modulators circumventing the reverse pH gradient in tumours.Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis.Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells.
P2860
Q27931241-1E4BAAA3-7955-47AF-8C25-B1B68A04C345Q27931285-78DFF6FA-6271-41B3-B7A6-402A71F7060AQ27936510-97E4AFAC-AF3A-4D5D-BFA4-342FBFD761C8Q27939700-24FA1AB6-7703-4ADB-B8B8-084FC296527BQ33699333-68106143-95CF-49D9-B0EE-3FDB70A3E19CQ34811649-8F861109-1462-4896-8A08-3CB5F6909371Q36955872-AC17DBF3-6345-4D95-9BE3-A3BADE85256CQ36969871-31E203A6-0B3C-4C82-977F-6F2025CA5156Q37856115-98DACAE2-3DB6-4646-8E5F-B5178C0367E1Q38213387-C8E3EB8C-5BAB-43C5-B89C-DC7217DCD0B3Q38366599-5BD53B3F-DAB2-4CA7-9382-C1863815A894Q43692525-3CC29261-1AB3-426F-83E5-A697DF58F66FQ46926444-5E9E5CB9-8330-4B88-B6E4-BBB960C673B5Q54100223-5987E40E-83EF-467C-A998-E65605A16F2E
P2860
Altered drug translocation mediated by the MDR protein: direct, indirect, or both?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Altered drug translocation mediated by the MDR protein: direct, indirect, or both?
@en
type
label
Altered drug translocation mediated by the MDR protein: direct, indirect, or both?
@en
prefLabel
Altered drug translocation mediated by the MDR protein: direct, indirect, or both?
@en
P2093
P2860
P356
P1476
Altered drug translocation mediated by the MDR protein: direct, indirect, or both?
@en
P2093
P2860
P2888
P304
P356
10.1007/BF02110444
P577
1996-12-01T00:00:00Z